Target intelligence / Profile preview

Actin-binding Rho-activating protein (ABRA)

Target
ABRA
Molecular classification
Other (Actin-binding signaling adaptor protein)
01

Overview

Actin-binding Rho-activating protein (ABRA), also known as Striated muscle activator of Rho signaling (STARS), is a conserved actin-binding protein highly enriched in cardiac, skeletal, and smooth muscle. ABRA localizes to the sarcomere, binding actin at the Z-disc and M-line, and regulates actin polymerization through interactions with actin-binding LIM (ABLIM) proteins. By promoting the conversion of G-actin to F-actin, ABRA removes G-actin-mediated inhibition of transcriptional co-activators (such as MRTFA), which allows these modulators to activate serum response factor (SRF)-dependent gene expression, thereby influencing muscle cell proliferation, differentiation, and response to mechanical and stress stimuli[1][3][4]. ABRA is downregulated in pathological states such as dilated cardiomyopathy and upregulated in muscle hypertrophy, playing a critical role in sarcomere integrity and as a modulator in muscle physiology and disease. Although it participates in key muscle signaling pathways, it is not currently considered a primary therapeutic target or receptor and no drugs are known to directly target ABRA[4][3][1].

Other names
Striated muscle activator of Rho signaling (STARS)Myocyte stress-1 (MS1)Actin binding Rho activating protein
02

Biological functions

Actin cytoskeleton organizationPositive regulation of Rho protein signal transductionPositive regulation of serum response factor (SRF)–dependent transcriptionRegulator of muscle cell proliferation, differentiation, and growth
03

Disease associations

Cardiovascular disease (notably, dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy)Skeletal muscle disease (role in muscle hypertrophy/atrophy)Other (possibly acts as a cytoskeletal intermediary in stress response signaling)
04

Biomarkers

Down-regulation is associated with dilated cardiomyopathy (DCM)Up-regulation is associated with muscle hypertrophy

Beyond the preview

Go deeper on Actin-binding Rho-activating protein (ABRA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin-binding Rho-activating protein (ABRA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call